The present invention provides an abuse deterrent oral fixed-dose composition, comprising a stimulant or opioid and an abuse deterrent active, wherein the abuse deterrent active is configured to be bioavailable only when the composition is crushed, ground or dissolved.
APOMORPHINE FOR THE TREATMENT OF METHYLPHENIDATE INDUCED HYPERACTIVITY